SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Reference Pricing For Drugs: Is It Compatible With U.S. Health Care?
2 references·8 citing·48 second hop
Reference Pricing For Drugs: Is It Compatible With U.S. Health Care? (2003)Reference Pricing For Drugs: Is It Compat…Outcomes of Reference Pricing for Angiotensin-Converting–Enzyme Inhibitors (2002)Outcomes of Reference Pricing…Review of the literature on reference pricing (2000)Review of the literature on r…Reference pricing and firms’ pricing strategies (2008)Reference pricing and firms’ …Paying for costly pharmaceuticals: regulation of new drugs in Australia, England and New Zealand (2008)Paying for costly pharmaceuti…Retail price markup commitment in decentralized supply chains (2007)Retail price markup commitmen…Vertically restrictive pricing in supply chains with price‐dependent demand (2006)Vertically restrictive pricin…Impacts of Cost Containment Strategies on Pharmaceutical Expenditures of the National Health Insurance in Taiwan, 1996???2003 (2006)Impacts of Cost Containment S…Do generics offer significant savings to the UK National Health Service? (2006)Do generics offer significant…PUBLIC POLICY SOURCES (2004)PUBLIC POLICY SOURCESReference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands and New Zealand (2003)Reference Pricing of Pharmace…Cost-Effectiveness Analysis and the Consistency of Decision Making (2001)NICE: faster access to modern treatments? Analysis of guidance on health technologies (2001)Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle (2004)Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act (1992)Generic Entry and the Pricing of Pharmaceuticals (1997)Generic Entry and the Pricing of Pharmaceuticals (1997)Generic medicines: Greek physicians’ perceptions and prescribing practices (2009)Generic Medicine Pricing Policies in Europe: Current Status and Impact (2010)Initiatives to enhance the quality and efficiency of statin and PPI prescribing in the UK: impact and implications (2010)Time Series Analysis: Forecasting and Control. (1978)Does Universal Health Insurance Make Health Care Unaffordable? Lessons From Taiwan (2003)Taiwan’s New National Health Insurance Program: Genesis And Experience So Far (2003)Hospital response to a global budget program under universal health insurance in Taiwan (2009)Performance impacts of interorganizational cooperation: a transaction cost perspective (2013)Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies (2014)Pricing: Making Profitable Decisions (1980)Supply Chain Coordination with Contracts (2003)Supply Chain Coordination with Revenue-Sharing Contracts: Strengths and Limitations (2005)Practical and effective contracts for the dominant retailer of a newsvendor product with price-sensitive demand (2011)Channel coordination with price discount mechanism under price‐sensitive market demand (2019)Stimulating sustainability investment level of suppliers with strategic commitment to price and cost sharing in supply chain (2019)Payment Restrictions for Prescription Drugs under Medicaid (1987)METHODS FOR ANALYZING HEALTH CARE UTILIZATION AND COSTS (1999)Adverse Events Associated With Prescription Drug Cost-Sharing Among Poor and Elderly Persons (2001)Proposal of the Physicians' Working Group for Single-Payer National Health Insurance (2003)Benefits And Risks Of Increasing Restrictions On Access To Costly Drugs In Medicaid (2004)The experiences of implementing generic medicine policy in eight countries: A review and recommendations for a successful promotion of generic medicine use (2013)Stability in Competition (1929)On Hotelling's "Stability in Competition" (1979)Stability in Competition (1990)International effects of national regulations: External reference pricing and price controls (2017)The Theory of Industrial Organization (1988)Role of Random Capacity Risk and the Retailer in Decentralized Supply Chains with Competing Suppliers (2014)Game theoretic models for a closed-loop supply chain with stochastic demand and backup supplier under dual channel recycling (2019)Dynamic pricing and lot sizing for a newsvendor problem with supplier selection, quantity discounts, and limited supply capacity (2021)Cross-national price differences for pharmaceuticals: how large, and why? (2000)The impact of price regulation on the launch delay of new drugs—evidence from twenty‐five major markets in the 1990s (2004)Retail price regulation and innovation: Reference pricing in the pharmaceutical industry (2009)Reference pricing with endogenous generic entry (2016)A Contribution to the Theory of Economic Growth (1956)On the mechanics of economic development (1988)Institutions, Institutional Change and Economic Performance (1991)Industrial Market Structure and Economic Performance. (1971)Industrial market structure and economic performance (1990)Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry (1991)Encouraging the use of generic medicines: implications for transition economies. (2002)Sustaining Generic Medicines Markets in Europe (2006)Marketing of the Life Sciences: A New Framework and Research Agenda for a Nascent Field (2009)
this work references cited by second hop

References

  • 2000Review of the literature on reference pricing203 cited
  • 2002Outcomes of Reference Pricing for Angiotensin-Converting–Enzyme Inhibitors178 cited

Cited by

  • 2006Impacts of Cost Containment Strategies on Pharmaceutical Expenditures of the National Health Insurance in Taiwan, 1996???200385 cited
  • 2006Do generics offer significant savings to the UK National Health Service?79 cited
  • 2003Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands and New Zealand73 cited
  • 2008Paying for costly pharmaceuticals: regulation of new drugs in Australia, England and New Zealand65 cited
  • 2008Reference pricing and firms’ pricing strategies64 cited
  • 2007Retail price markup commitment in decentralized supply chains32 cited
  • 2006Vertically restrictive pricing in supply chains with price‐dependent demand28 cited
  • 2004PUBLIC POLICY SOURCES12 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work